Диссертация (1139911), страница 19
Текст из файла (страница 19)
Histopathol. – 2004. –V.19. – P. 259–270.145. Cury V., Moretti A.I.S., Assis L., Bossini P., Crusca J.S., Low levellaser therapy increases angiogenesis in a model of ischemic skin flap in rats123mediated by VEGF, HIF-1α and MMP-2 // Journal of Photochemistry andPhotobiology B: Biology. – V. 125. – P. 164-170.146. Dahlin J.S., Hallgren J. Mast cell progenitors: Origin, development andmigration to tissues // Mol Immunol. – 2014. pii. – P.
S0161-5890(14)000340.147. Dörtbudak O., Haas R., Mallath-Pokorny G. Biostimulation of bonemarrow cells with a diode soft laser // Clin Oral Implants Res. – 2000. – V.11(6). – P. 540-5.148. Douaiher J., Succar J., Lancerotto L., Gurish M.F., Orgill D.P.,Hamilton M.J., Krilis S.A., Stevens R.L. Development of mast cells andimportance of their tryptase and chymase serine proteases in inflammationand wound healing // Adv Immunol. – 2014.
– V. 122. – P. 211-252.149. Dvorak A.M. Ultrastructural studies of human basophils and mast cells// J Histochem Cytochem. – 2005. – V.53, N9. – P.1043-1070.150. Dy M. Histamine-cytokine connection in immunity and hematopoiesis /M. Dy, E.
Schneider // Cytokine and Growth Factor Reviews. – 2004. – V.15.– P.393-410.151. EbrahimiT.,MoslemiN.,RoknA.R.,HeidariM.,Nokhbatolfoghahaie H. The Influence of Low-Intensity Laser Therapy onBone Healing // J Dent (Tehran) . – 2012. – V. 9(4). – P. 238–248.152. Ebrahimi T., Moslemi N., Rokn A., Heidari M., NokhbatolfoghahaieH., Fekrazad R. The influence of low-intensity laser therapy on bone healing// J Dent (Tehran). – 2012. – V. 9(4). – P.
238-48.153. Ekström K., Valadi H., Sjöstrand M., Malmhäll C., Bossios A., EldhM., Lötvall J. Characterization of mRNA and microRNA in human mast cellderived exosomes and their transfer to other mast cells and blood CD34progenitorcells//JExtracellVesicles.-2012.–V.1.doi:10.3402/jev.v1i0.18389.124154. el Sayed S.O., Dyson M. Effect of laser pulse repetition rate and pulseduration on mast cell number and degranulation // Lasers Surg Med.
– 1996. –V. 19(4). – P. 433-7.155. El-Maghraby E.M., El-Rouby D.H., Saafan A.M. Assessment of theeffect of low-energy diode laser irradiation on gamma irradiated rats'mandibles // Arch Oral Biol. – 2013. – V. 58(7). – P. 796-805.156. Engels W., Reiters P.H., Daemen M.J., Smits J.F., van der Vusse G.J.Transmural changes in mast cell density in rat heart after infarct induction invivo. // J Pathol. – 1995. – V.
177(4). – P. 423-429.157. EngelsW.,ReitersP.H.Daemen,M.J.Smits,J.F.VanderVusse G.J. Transmural changes in mast cell density in rat heart after infarctinduction in vivo. //J Pathol.- 1995.-177:423–429158. Entman M.L., Youker K.A., Frangogiannis N., Lakshminarayanan V.,Nossuli T., Evans A., Kurrelmeyer K., Mann D.L., Smith C.W.
Isinflammation good for the ischemic heart--perspectives beyond the ordinary //Z Kardiol. – 2000. – V. 89 Suppl 9. – P. IX/82-7.159. Epelman S., Mann D.L. Communication in the Heart: the Role of theInnate Immune System in Coordinating Cellular Responses to Ischemic Injury// Journal of Cardiovascular Translational Research. – 2012.
– V.5 - P. 827836160. Fairweather D., Frisancho-Kiss S., Yusung S.A., Barrett M.A., DavisS.E., Gatewood S.J., Njoku D.B., Rose N.R. Interferon-gamma protectsagainst chronic viral myocarditis by reducing mast cell degranulation,fibrosis, and the profibrotic cytokines transforming growth factor-beta 1,interleukin-1 beta, and interleukin-4 in the heart // Am J Pathol. – 2004. – V.165(6). – P. 1883-94.161. Fantacci M., Bianciardi P., Caretti A. Carbamylated erythropoietinameliorates the metabolic stress induced in vivo by severe chronic hypoxia //Proc.
Natl. Acad. Sci. USA. – 2006. – V. 103. – N 46. – Р. 17531–17536.125162. Ferrario M., Arbustini E., Massa M., Rosti V., Marziliano N., RaineriC., et al. High-dose erythropoietin in patients with acute myocardialinfarction: a pilot, randomised, placebo-controlled study // Int J Cardiol. –2011. – V. 147. – P.
124-131.163. Fiore P., Panza F., Cassatella G., Russo A., Frisardi V., Solfrizzi V.,Ranieri M., Di Teo L., Santamato A. Short-term effects of high-intensity lasertherapy versus ultrasound therapy in the treatment of low back pain: arandomized controlled trial // Eur J Phys Rehabil Med. – 2011. – V. 47(3). –P. 367-373.164. Fischer-Rasokat U., Assmus B., Seeger F.H. et al.
A pilot trial to assesspotential effects of selective intracoronary bone marrow-derived progenitorcell infusion in patients with nonischemic dilated cardiomyopathy: final 1year results of the transplantation of progenitor cells and functionalregeneration enhancement pilot trial in patients with nonischemic dilatedcardiomyopathy // Circ Heart Fail. – 2009. – V.
2. – P. 417–423.165. Fisher S.A. Bone Marrow Stem Cell Treatment for Ischemic HeartDisease in Patients with No Option of Revascularization: A SystematicReview and Meta-Analysis / Fisher SA, Dorée C, Brunskill SJ, Mathur A,Martin-Rendon E // PLoS One. 2013. – V. 8(6). – P. e64669.166. Forman M.F., Brower G.L., Janicki J.S.
Rat cardiac mast cellmaturation and differentiation following acute ventricular volume overload //Inflamm Res. 2006. – V. 55. – P. 408–415.167. Frangogiannis N.G. The inflammatory response in myocardial injury,repair, and remodeling // Nat Rev Cardiol. – 2014 May.
– V. 11(5). – P. 255265.168. Frossi B. The mast cell: an antenna of the microenvironment thatdirects the immune response. / B. Frossi, M. De Carli, C. Pucillo // J LeukocBiol. – 2004. – V.75, N4. – P.579-585.126169. Fujimaki Y. Low-level laser irradiation attenuates production ofreactive oxygen species by human neutrophils / Y. Fujimaki [et al] // J ClinLaser Med Surg. – 2003.
– V.21, N3. – P.165-170.170. Gaber M.A., Seliet I.A., Ehsan N.A., Megahed M.A. Mast cells andangiogenesis in wound healing // Anal Quant Cytopathol Histpathol. - 2014. –V.36(1). – P.32-40.171. Gailit J., Marchese M.J., Kew R.R., Gruber B.L. The differentiationand function of myofibroblasts is regulated by mast cell mediators // J InvestDermatol.
– 2001. – V. 117(5). – P. 1113-1119.172. Galli S.J. Mast cells and basophils // Curr. Opin. Hematol. – 2000. –V.4. – P.840-845.173. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M.,Williams C.M.,TsaiM.Mastcellsas‘tunable’effectorandimmunoregulatory cells: recent advances // Annu.
Rev. Immunol. – 2005. –V.23. - P.749-786174. Garavello I. The effects of low laser irradiation on angiogenesis ininjured rat tibiae / I. Garavello, V. Baranauskas, M.A. da Cruz-Hofling //Histol Histopathol. – 2004. – V.19, N1. – P.43-48.175. Ghodsizad A., Bordel V., Bruckner B., Loebe M., Fuerst G., MirsaidiI., Sucker M., Ruhparwar A., Karck M., Klein H.M. Clinical labeling andimaging of transplanted CD133+/CD34+ stem cells in patients with ischemicheart disease.// Heart Surg Forum.
– 2012. – V. 15(2). – P. E116-18.176. Giannelli M., Chellini F., Sassoli C., Francini F., Photoactivation ofbone marrow mesenchymal stromal cells with diode laser: effects andmechanisms of action // J Cell Physiol. – 2013. – V. 228(1). – P. 172-181177. Gilles S., Zahler S., Welsch U., Sommerhoff C.P., Becker B.F. Releaseof TNF-alpha during myocardial reperfusion depends on oxidative stress andis prevented by mast cell stabilizers // Cardiovasc Res.
– 2003. – V. 60(3). –P. 608-616.127178. Global status report on noncommunicable diseases 2014. 2014.–280p.-WHO,http://www.who.int/global-coordination-mechanism/publications/global-status-report-ncds-2014-eng.pdf179. Gnecchi M., Danieli P., Cervio E. Mesenchymal stem cell therapy forheart disease // Vascul Pharmacol.
– 2012. – V. 57(1). – P. 48-55.180. Gowdak L.H., Schettert I.T., Rochitte C.E., Lisboa L.A., Dallan L.A.,Cesar L.A., Krieger J.E., Ramires J.A., Oliveira S.A. Cell therapy plustransmyocardial laser revascularization for refractory angina // Ann ThoracSurg. – 2005. – V.80(2). – P. 712-714181. Grable J. Comparative cytokine release from human monocytes, mastcells and human mast cell line / J. Grable, P.
Welker, A. Meller // J invest.Derm. – 1994. – V.103. – P.504-511.182. Gurish M.F. Mast cell growth, differentiation, and death / M.F. Gurish,J.A. Boyse // Clin Rev Allеrgy Immunol. – 2002. – V.22, N2. – P.107-125.183. Guven Bagla A., Ercan E., Asgun H.F., Ickin M., Ercan F., Yavuz O.,Bagla S., Kaplan A. Experimental acute myocardial infarction in rats: HIF-1α,caspase-3, erythropoietin and erythropoietin receptor expression and thecardioprotective effects of two different erythropoietin doses // ActaHistochem. – 2013.
– V.115. – P.658-68.184. Guzzardella G.A., Fini M., Torricelli P., Giavaresi G., Giardino R..Laser stimulation on bone defect healing: an in vitro study // Lasers Med Sci.– 2002. – V. 17(3). – P. 216–20.185. Hallgren J. Pathways of murine mast cell development and trafficking:tracking the roots and routes of the mast cell / J. Hallgren, M.F. Gurish //Immunological Reviews.
– 2007. – V.217, N1. – P.8-18.186. Hasselblatt M., Ehrenreich H., Sirén A.L. The brain erythropoietinsystem and its potential for therapeutic exploitation in brain disease // J.Neurosurg. Anesthesiol. – 2006. – V. 18. – N 2. – Р.132–138.187. Hatzistergos K.E., Quevedo H., Oskouei B.N., Hu Q., FeigenbaumG.S., Margitich I.S., Mazhari R., Boyle A.J., Zambrano J.P., Rodriguez J.E.,128Dulce R., Pattany P.M., Valdes D., Revilla C., Heldman A.W., McNiece I.,Hare J.M. Bone marrow mesenchymal stem cells stimulate cardiac stem cellproliferation and differentiation // Circulation Research.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
